Kunal Jobanputra MD, DM (@knjobanputra) 's Twitter Profile
Kunal Jobanputra MD, DM

@knjobanputra

Medical Oncologist | @tatamemorial & KEM Mumbai alumnus | #GUOnc #BreastOnc #ThoracicOnc #lymphoma #SupportiveCare #GlobalOnc

ID: 985857518193823746

linkhttp://drkunaljobanputra.com calendar_today16-04-2018 12:28:43

1,1K Tweet

834 Followers

477 Following

Vedang Murthy (@vedangmurthy) 's Twitter Profile Photo

1/6 New Article Alert Hot in @BMJ_Oncology, our prospective study investigates the 🤔 #Bladdercancer treatment dilemma: 🔪 Radical cystectomy vs 🎯 Bladder preservation have Similar survival, but what about QOL? Tata Memorial Hospital TMC Radiation Oncology Sheetal R Kashid

1/6 New Article Alert
Hot in @BMJ_Oncology, our prospective study investigates the 🤔 #Bladdercancer treatment dilemma: 🔪 Radical cystectomy vs 🎯 Bladder preservation have Similar survival, but what about QOL? 
<a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/RadOncTMC/">TMC Radiation Oncology</a> <a href="/sheetalrkashid/">Sheetal R Kashid</a>
Biagio Ricciuti, MD PhD (@biagioricciutmd) 's Twitter Profile Photo

NIPPON (JCOG2007): Chemo + pembro vs chemo + nivo–ipi as 1st line Tx for #NSCLC. OncoAlert ❌ No difference in PFS/OS 🏥Terminated early due to safety issues (7% treatment-related deaths w/ nivo/ipi) ➡️ underpowered to derive a definitive conclusion and for robust key

Prof Vikas Ostwal (@vikaso) 's Twitter Profile Photo

Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD—High Study) | JCO Global Oncology ascopubs.org/doi/full/10.12… Anant Ramaswamy Viraj Lavingia Aditya Dhanawat

Kunal Jobanputra MD, DM (@knjobanputra) 's Twitter Profile Photo

Incidence of MRONJ in patients with breast cancer - ⌛️ 20 year follow-up (most of the trials and data available so far has shorter follow-up) 💡MRONJ in patients on Denosumab - 11.6% 🤯 ✅ Dental eval must prior to anti-resorptive Rx ⁦OncoAlert⁩ ascopubs.org/doi/10.1200/JC…

Kunal Jobanputra MD, DM (@knjobanputra) 's Twitter Profile Photo

Interesting trial of SBRT for oligoprogressive cancers - Initially planned for NSCLC patients, but due to poor accrual, included all histologies! 35% in SoC arm treated with SBRT ➡️ unwillingness to forgo ablative treatments on SoC arm! ⁦TMC Radiation Oncology⁩ redjournal.org/article/S0360-…

Kunal Jobanputra MD, DM (@knjobanputra) 's Twitter Profile Photo

Nicely summed up all the excellent work at Tata Memorial Hospital and across all departments. Quality, Consistency, Accuracy and Research inspite of huge patient volumes. Students asking why one should select TMH for training, all answers here! Vedang Murthy

Dr. John Cush (@rheumnow) 's Twitter Profile Photo

It takes >3-4 weeks of steroids (@ any dose >5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of <3-4 wks, irrespective of dose, DOES NOT require GC tapering buff.ly/4gggMq6

It takes &gt;3-4 weeks of steroids (@ any dose &gt;5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of &lt;3-4 wks, irrespective of dose, DOES NOT require GC tapering buff.ly/4gggMq6
sganguly (@bmtdoc63) 's Twitter Profile Photo

Ifosfamide Can cause encephalopathy especially in patients with hypoalbuminemia. IV albumin prophylaxis. IV methylene blue treatment. Ifos can cause Type II RTA with NAG acidosis, hypokalemia, hypophosphatemia & Fanconi type proteinuria and glucosuria. MESNA cannot prevent this.

Kunal Jobanputra MD, DM (@knjobanputra) 's Twitter Profile Photo

We may discuss about colon cancer screening in India, but unfortunately the fact remains that we still miss diagnosing them at earlier stages as the cause of iron deficiency anemia is not investigated, particularly in the elderly. #coloncancer

Kunal Jobanputra MD, DM (@knjobanputra) 's Twitter Profile Photo

Two important things in life as described by Morgan Housel : patience & scarcity. Patience to let something grow. Scarcity to admire what it grows into. #SameAsEver #nowreading